Attenuated expression of IL-10 may alleviate immunosuppression of other myeloid effector cells, as TAM-derived IL-10 has been shown to inhibit IL-12 production in intratumoral dendritic cells, leading to suppression of anti-tumor CD8+ T cell activation33. This evidence concerns the gene CD8A and neoplasm.